| Literature DB >> 33671471 |
Christine M Khella1, Rojiar Asgarian1, Judith M Horvath1, Bernd Rolauffs1, Melanie L Hart1.
Abstract
Understanding the causality of the post-traumatic osteoarthritis (PTOA) disease process of the knee joint is important for diagnosing early disease and developing new and effective preventions or treatments. The aim of this review was to provide detailed clinical data on inflammatory and other biomarkers obtained from patients after acute knee trauma in order to (i) present a timeline of events that occur in the acute, subacute, and chronic post-traumatic phases and in PTOA, and (ii) to identify key factors present in the synovial fluid, serum/plasma and urine, leading to PTOA of the knee in 23-50% of individuals who had acute knee trauma. In this context, we additionally discuss methods of simulating knee trauma and inflammation in in vivo, ex vivo articular cartilage explant and in vitro chondrocyte models, and answer whether these models are representative of the clinical inflammatory stages following knee trauma. Moreover, we compare the pro-inflammatory cytokine concentrations used in such models and demonstrate that, compared to concentrations in the synovial fluid after knee trauma, they are exceedingly high. We then used the Bradford Hill Framework to present evidence that TNF-α and IL-6 cytokines are causal factors, while IL-1β and IL-17 are credible factors in inducing knee PTOA disease progresssion. Lastly, we discuss beneficial infrastructure for future studies to dissect the role of local vs. systemic inflammation in PTOA progression with an emphasis on early disease.Entities:
Keywords: Bradford Hill; IL-17; IL-1β; IL-6; TNF-α; acute; articular cartilage; cartilage; cartilage repair; chondrocyte; chronic; clinical; complement; early PTOA; early disease; immunomodulation; in vitro models; inflammation; inflammatory cytokines; injury; knee joint; knee trauma; osteoarthritis; post-traumatic osteoarthritis; subacute; synovial fluid
Mesh:
Substances:
Year: 2021 PMID: 33671471 PMCID: PMC7922905 DOI: 10.3390/ijms22041996
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923